NCT05061368: Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD
- State
- Under way
- Phase
- Phase 2
- People
- 160 planned
- Started
- 1 Mar 2022
- Primary completion
- May 2027
- Arms
- Sildenafil
- Results
- None posted
- 29 Sep 2021: Trial registered
- 1 Mar 2022: Trial started